(2835) Utilization of Clinical-Grade Metagenomics in Urinary Tract Infection Diagnostics: Improving High-Risk Patients’ Outcomes with a Genomic-Based Assay

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

EM

Eduardo J. Morfa Romero, MD

SUNY Downstate Health Sciences University
Brooklyn, New York, United States
MA

Michael Augenbraun, MD

Division Chief
SUNY Downstate Medical University
Brooklyn, NY, United States
TR

Tiara Rivera, B.S.

NGS Technician
Biotia
Brooklyn, New York, United States
SR

Sol Rey, BS

Biotia Inc.
Brooklyn, New York, United States
XJ

Xavier O. Jirau Serrano, MS

NGS Research Scientist
Biotia Inc.
New York, New York, United States
JP

John C. Papciak, BS

Biotia Inc.
New York, New York, United States
SP

Suraj S. Patel, n/a

Biotia Inc., New York, NY, USA
Elmhurst, New York, United States
BH

Bridget Harrison, B.A.

Clinical Program Manager
Biotia
Brooklyn, New York, United States
AP

Anna Plourde, MD, MPH

SUNY Downstate Medical Center
Brooklyn, New York, United States
CO

Caitlin Otto, PhD, D(ABMM)

Biotia Inc.
New York, New York, United States
CM

Chris Mason, Ph.D.

Biotia
New York, New York, United States
Heather L. Wells, MPH, PhD Candidate

Consultant
Biotia
New York, New York, United States
DD

David C. Danko, Ph.D.

CTO
Biotia
Manhattan, New York, United States
NO

Niamh B. O'Hara, PhD

Chief Executive Officer and Co-Founder
Biotia Inc.
New York, New York, United States
MC

Mara Couto-Rodriguez, MS

Clinical Research Scientist
Biotia Inc.
New York, New York, United States

Dorottya Nagy-Szakal, MD PhD (she/her/hers)

Chief Medical Officer
Biotia Inc.
New York, New York, United States